🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be an open label cluster randomized study with two active interve...
Status
Unknown
Location
Malaria Consortium
Start Date
2023-07-15
Trial ID
NCT05946642
The purpose of this study is to evaluate the effectiveness of repurposed me...
Status
Completed
Location
Lamb Health, LLC
Start Date
2022-02-16
Trial ID
NCT05894538
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of repurposed me...
Status
Completed
Location
Lamb Health, LLC
Start Date
2021-06-08
Trial ID
NCT05736861
Treatments Being Tested
The trial will develop and validate a platform for quantitative assessment ...
Status
Recruiting
Location
Universidade Federal de Minas Gerais
Start Date
2021-09-30
Trial ID
NCT05041907
Treatments Being Tested
This study aims first to assess the efficacy, safety, and effectiveness of ...
Status
Unknown
Location
SZUMC
Start Date
2020-03-28
Trial ID
NCT05925140
An open-label, randomized by school, two-arm pragmatic trial, will be condu...
Status
Recruiting
Location
Ghana Health Service (GHS)
Start Date
2025-09-01
Trial ID
NCT06282315
Scabies is a parasitic pathology contracted mainly through human contaminat...
Status
Unknown
Location
Hopital Saint Antoine - Polyclinique Beaudelaire
Start Date
2022-04
Trial ID
NCT05271968
Treatments Being Tested
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
At present, there are no specific treatments for COVID-19. WHO recommends f...
Status
Unknown
Location
Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation)
Start Date
2020-04-25
Trial ID
NCT04373824
Treatments Being Tested
Study objectives: * To compare efficacy and safety of Ivermectin 1% cream ...
Status
Completed
Location
Galderma Investigational Site
Start Date
2012-04
Trial ID
NCT01493947
Treatments Being Tested